Dermorphin Research Guide

Full name: Dermorphin (Opioid Heptapeptide)

A naturally occurring opioid heptapeptide originally isolated from the skin of South American frogs. It is an extremely potent mu-opioid agonist studied for analgesia, and is included here strictly for educational reference given its controlled, high-risk profile.

How Dermorphin Works

Binds mu-opioid receptors with very high affinity and selectivity, producing potent analgesia. Its unusual D-alanine residue makes it resistant to breakdown, contributing to a much stronger effect than morphine on a per-weight basis.

Dosing Protocol

• Typical dose: Not established for human use
• Frequency: Research only
• Duration: Research only
• Route: Injection (research)

Reported Benefits

• Potent analgesia (research context)
• High mu-opioid receptor selectivity (research interest)

Potential Side Effects

• Respiratory depression
• Sedation
• Dependence and addiction risk
• Overdose risk
• No approved human use

Research Citations

1. Dermorphin opioid potency (2010) - Characterized as a highly potent, selective mu-opioid agonist far stronger than morphine by weight.

Related Pain & Inflammation Compounds

• Low-Dose Naltrexone (LDN) - Full Profile
• PEA - Full Profile
• Diclofenac Topical - Full Profile
• Pentosan (Joint Pain) - Full Profile
• ARA-290 - Full Profile
• Boswellia (AKBA) - Full Profile

View full Dermorphin profile with 3D molecule viewer →